70.00
-6.85 (-8.91%)
-6.85 (-8.91%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 2,892,812 |
|
|||||
| News | - | ||||||
| Day High | 76.85 | Low High |
|||||
| Day Low | 68.1606 | ||||||
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CRISPR Therapeutics AG | CRSP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -6.85 | -8.91% | 70.00 | 20:00:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 76.85 | 68.1606 | 76.85 | 70.09 | 76.85 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 53,153 | 2,892,812 | $ 71.66 | $ 207,294,638 | - | 68.1606 - 220.21 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:28 | 5 | $ 69.84 | USD |
Period:
Draw Mode:
CRISPR Therapeutics AG Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 5.36B | 76.53M | 52.74M | $ 719.00k | $ 328.15k | -5.29 | 15.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 152.45k | 2.00% |
CRISPR Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRSP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 79.57 | 82.00 | 68.1606 | 77.74 | 1,362,636 | -9.57 | -12.03% |
| 1 Month | 93.0775 | 95.00 | 68.1606 | 83.51 | 1,396,666 | -23.08 | -24.79% |
| 3 Months | 122.43 | 124.79 | 68.1606 | 96.71 | 1,430,815 | -52.43 | -42.82% |
| 6 Months | 112.94 | 169.67 | 68.1606 | 114.93 | 1,327,383 | -42.94 | -38.02% |
| 1 Year | 132.89 | 220.21 | 68.1606 | 132.93 | 1,658,224 | -62.89 | -47.32% |
| 3 Years | 39.95 | 220.21 | 21.65 | 96.32 | 1,116,155 | 30.05 | 75.22% |
| 5 Years | 19.10 | 220.21 | 11.63 | 82.67 | 920,398 | 50.90 | 266.49% |
CRISPR Therapeutics Description
| CRISPR Therapeutics AG is a gene-editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 is a technology that allows for precise, directed changes to genomic DNA. The company advanced programs target beta-thalassemia and sickle cell disease, two hemoglobinopathies that have a high unmet medical need. |
